{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:15:29Z","timestamp":1780542929201,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1245\/s10434-026-19268-y","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:50:26Z","timestamp":1773424226000},"page":"5470-5477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HMGB1, An Autophagy-Associated Gene, as a Novel Non-Invasive Diagnostic Biomarker: Clinicopathologic Correlation in Urinary Bladder Carcinoma Patients"],"prefix":"10.1245","volume":"33","author":[{"given":"Sahil","family":"Data","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashasvi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujwal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. N.","family":"Shankhwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviral","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita Ghosh","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Zarekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"19268_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11010-021-04299-8","volume":"477","author":"A Singh","year":"2022","unstructured":"Singh A, Gupta N, Khandakar H, Kaushal S, Seth A, Pandey RM, Sharma A. Autophagy-associated HMGB-1 as a novel potential circulating noninvasive diagnostic marker for detection of urothelial carcinoma of bladder. Mol Cell Biochem. 2022;477:493\u2013505.","journal-title":"Mol Cell Biochem."},{"key":"19268_CR2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","volume":"76","author":"M Babjuk","year":"2019","unstructured":"Babjuk M, Burger M, Capoun O, et al. European Association of Urology guidelines on non-muscle invasive bladder cancer (TaT1 and carcinoma in situ): 2019 update. Eur Urol. 2019;76:639\u201357.","journal-title":"Eur Urol."},{"key":"19268_CR3","unstructured":"EAU Guidelines. Edn. Presented at the EAU Annual Congress Madrid 2025. ISBN 978-94-92671-29-5."},{"key":"19268_CR4","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. (2024). Global cancer observatory: cancer today. Lyon, France: International agency for research on cancer. Available at https:\/\/gco.iarc.who.int\/today."},{"key":"19268_CR5","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney LALM. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38:1895\u2013904.","journal-title":"World J Urol."},{"key":"19268_CR6","unstructured":"https:\/\/main.icmr.nic.in\/sites\/default\/files\/whats_new\/Draft_Consens us_Document_Urinary_Bladder_cancer.pdf."},{"key":"19268_CR7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/life14070789","volume":"14","author":"M Bakula","year":"2024","unstructured":"Bakula M, Hudolin T, Knezevic N, et al. Intravesical gemcitabine and docetaxel therapy for BCG-na\u00efve patients: a promising approach to non-muscle invasive bladder cancer. Life Basel. 2024;14:789. https:\/\/doi.org\/10.3390\/life14070789. (Published 22 June 2024).","journal-title":"Life Basel."},{"key":"19268_CR8","first-page":"43","volume":"22","author":"RS Matulewicz","year":"2020","unstructured":"Matulewicz RS, Steinberg GD. Non-muscle-invasive bladder cancer: overview and contemporary treatment landscape of neoadjuvant chemoablative therapies. Rev Urol. 2020;22:43\u201351.","journal-title":"Rev Urol."},{"key":"19268_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ccr.2006.06.001","volume":"10","author":"K Degenhardt","year":"2006","unstructured":"Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell. 2006;10:51\u201364.","journal-title":"Cancer Cell."},{"key":"19268_CR10","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/cdd.2009.149","volume":"17","author":"R Kang","year":"2010","unstructured":"Kang R, Tang D, Schapiro NE, Livesey KM, Farkas A, Loughran P, et al. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ. 2010;17:666\u201376.","journal-title":"Cell Death Differ."},{"key":"19268_CR11","doi-asserted-by":"publisher","first-page":"C1318","DOI":"10.1152\/ajpcell.00616.2005","volume":"291","author":"CW Bell","year":"2006","unstructured":"Bell CW, Weiwen JW, Reich CF III, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol. 2006;291:C1318\u201325.","journal-title":"Am J Physiol Cell Physiol."},{"key":"19268_CR12","first-page":"1882","volume":"23","author":"D Suren","year":"2018","unstructured":"Suren D, Yildirim HT, Atalay I, Sayiner A, Yildirim M, Alikanoglu AS, Sezer C. HMGB1 expression in urothelial carcinoma of the bladder. JBUON. 2018;23:1882\u20136.","journal-title":"JBUON."},{"key":"19268_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-0716-0247-8_2","volume-title":"Immune mediators in cancer","author":"W Chen","year":"2020","unstructured":"Chen W, Bao G, Zhao L, Wang H. Analysis of circulating HMGB1 in human serum. In: Immune mediators in cancer. New York: Humana, Springer; 2020. p. 15\u201328."},{"key":"19268_CR14","doi-asserted-by":"publisher","unstructured":"Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, Zeh HJ, Lotze MT. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene. 2010;29(38):5299\u2013310. https:\/\/doi.org\/10.1038\/onc.2010.261. Epub 2010 Jul 12. Erratum in: Oncogene. 2025;44(32):2927\u20132928. https:\/\/doi.org\/10.1038\/s41388-025-03510-0. PMID: 20622903; PMCID: PMC2945431.","DOI":"10.1038\/onc.2010.261"},{"key":"19268_CR15","doi-asserted-by":"publisher","first-page":"1593157","DOI":"10.3389\/fonc.2025.1593157","volume":"15","author":"D Li","year":"2025","unstructured":"Li D, Lei X, Zhao L, Fu Q, Chen Y, Yang X. Mechanism of action of HMGB1 in urologic malignancies. Front Oncol. 2025;15:1593157.","journal-title":"Front Oncol."},{"key":"19268_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110904","volume":"112","author":"S Idoudi","year":"2023","unstructured":"Idoudi S, Bedhiafi T, Pedersen S, et al. Role of HMGB1 and its associated signaling pathways in human malignancies. Cell Signal. 2023;112:110904.","journal-title":"Cell Signal."},{"key":"19268_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s12672-025-02466-7","volume":"16","author":"M Xu","year":"2025","unstructured":"Xu M, Hu L, Chen Z, Liang T, Li J. Correlation between HMGB1 expression and drug resistance and prognosis in patients with bladder urothelial carcinoma. Discov Oncol. 2025;16:695.","journal-title":"Discov Oncol."},{"key":"19268_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/jso.23040","volume":"106","author":"GL Yang","year":"2012","unstructured":"Yang GL, Zhang LH, Bo JJ, et al. Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer. J Surg Oncol. 2012;106:57\u201361.","journal-title":"J Surg Oncol."},{"key":"19268_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4103\/2278-330X.187577","volume":"5","author":"TB Yuvaraja","year":"2016","unstructured":"Yuvaraja TB, Ganesh SW, Bakshi GP. Genitourinary cancers: summary of Indian data. South Asian J Cancer. 2016;5:122\u20134.","journal-title":"South Asian J Cancer."},{"key":"19268_CR20","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, et al. Bladder cancer. Lancet. 2016;388:2796\u2013810.","journal-title":"Lancet."},{"key":"19268_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034318","volume":"7","author":"H Lee","year":"2012","unstructured":"Lee H, Song M, Shin N, Shin CH, Min BS, Kim HS, et al. Diagnostic significance of serum HMGB1 in colorectal carcinomas. PLoS One. 2012;7:e34318. https:\/\/doi.org\/10.1371\/journal.pone.0034318. (Epub 4 April 2012. PMID: 22496788; PMCID: PMC3319566).","journal-title":"PLoS One."},{"key":"19268_CR22","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3892\/or.2015.3782","volume":"33","author":"QY Zhang","year":"2015","unstructured":"Zhang QY, Wu LQ, Zhang T, Han YF, Lin X. Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1\/2. Oncol Rep. 2015;33:1630\u20138. https:\/\/doi.org\/10.3892\/or.2015.3782. (Epub 4 Feb 2015. PMID: 25652880; PMCID: PMC4358082).","journal-title":"Oncol Rep."},{"key":"19268_CR23","doi-asserted-by":"publisher","unstructured":"Benlier N, Solakhan M, Y\u0131ld\u0131r\u0131m Z, Kaya V, Y\u0131ld\u0131r\u0131m \u00d6A, Orhan N, \u00c7i\u00e7ek H, Y\u0131ld\u0131r\u0131m M. A novel diagnostic tool for thedetection of bladder cancer: Measurement of urinary high mobility group box-1. Urol Oncol Semin Orig Investig. 2020;38(8):685.e11\u2013685.e16. https:\/\/doi.org\/10.1016\/j.urolonc.2020.03.025","DOI":"10.1016\/j.urolonc.2020.03.025"},{"key":"19268_CR24","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.2147\/OTT.S155745","volume":"11","author":"C Huang","year":"2018","unstructured":"Huang C, Huang Z, Zhao X, Wang Y, Zhao H, Zhong Z, Wang L. Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma. Onco Targets Ther. 2018;11:2111\u201320.","journal-title":"Onco Targets Ther."},{"key":"19268_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/egjp.egjp_9_22","volume":"42","author":"DA Ibrahim","year":"2022","unstructured":"Ibrahim DA, Abdelrahman DI. Evaluation of RUNX2 and HMGB1 expression as markers of tumor aggressiveness in urothelial carcinoma. Egypt J Pathol. 2022;42:37\u201343.","journal-title":"Egypt J Pathol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19268-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19268-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19268-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:28:43Z","timestamp":1778869723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19268-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["19268"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19268-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}